ReAct - Action on Antibiotic Resistance

ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.

Theme

COVID-19 and antibiotic resistance

Articles relating to COVID-19 and antibiotic resistance.

News

4 key reflections on the recently launched WHO GLASS-report

The WHO GLASS-report summarizing antimicrobial resistance data from 2018 was launched end of May this year. The report is built on data reported from 78 of the 82 countries that were enrolled in GLASS at the end of the data call – 31st of July 2019 – and includes information extracted from over two million infected patients. In this article, ReAct highlights important findings in the report, describes the progress of GLASS and points out pitfalls to be aware of when interpreting the data.

Policy

Key points from ReAct’s comments to the Independent Panel on Evidence

Earlier this week, ReAct provided feedback on the establishment of an Independent Panel on Evidence for Action against Antimicrobial Resistance. Also, the Antibiotic Resistance Coalition came together around a joint response on the proposed Terms of Reference that the Tripartite Joint Secretariat on AMR had issued a public discussion on.

ReAct Interview

From zoologist to community engagement on AMR

Being a zoologist, Jessica Mitchell worked in different countries traveling to remote sites and engaged with the local communities. She enjoyed being able to bring her biological knowledge to an applied problem and support communities to develop their own solutions.

This is when she realized she wanted to develop her human behavior skillset and at the same time use her biology background to address applied problems – such as antimicrobial resistance.

Science

Learning from bedaquiline in South Africa – comprehensive health systems for new antibiotics

A key component of delivering new antibiotics to market is ensuring that they are used appropriately. To learn how this can be done, ReAct looked into how bedaquiline, a new anti-tuberculosis drug was introduced in South Africa. A key learning point from the project was that the requirements for sustainable use of antibiotics correlate with the building blocks of a strong health system – health systems strengthening and responsible use of antibiotics go hand in hand.

Science

Shortages and AMR – why should we care? 4 consequences of antibiotic shortages

Shortages of antibiotics have become a global problem that also affect countries with robust healthcare and regulatory systems. The causes are several, sometimes difficult to oversee, and the solutions are not as easy to implement as they are to conceptualize. Shortages of medicines in general cause patients to lose access to important treatments and, as such, lead to increased costs, morbidity and even mortality. But shortages of antibiotics may also lead to increases in antibiotic resistance.

In focus

Learn more! AMR and its impact on UHC, SDGs and the urgent need to fund AMR work

Here you find links to articles, reports and short videos – to learn more about the impact of Antimicrobial Resistance on Universal Health Coverage, the Sustainable Development Goals and the urgent need to find ways to finance efforts to manage antimicrobial resistance.

We are global

ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.